Changes on corpus luteum structure and progesterone synthesis pathway after hCG or GnRH treatment during the early luteal phase in sheep.

This study investigated the effect of hCG or GnRH on structural changes of the corpora lutea (CL) and the regulation of the expression of steroidogenic enzymes involved in P4 secretion in post-ovulatory (po-CL) and accessory CL (acc-CL). Sixty-four ewes were assigned to three groups receiving: 300 IU of hCG (hCG) or 4 µg Buserelin (GnRH) or 1 mL of saline solution (Control) on Day (d) 4 post artificial insemination (FTAI). Laparoscopic ovarian were performed on d 4, 14 and, 21 post-FTAI to determine the numbers of CL. Blood samples were collected for serum LH and P4 analysis. On d 14 post-FTAI, both CL were removed from the ovary to determine large luteal cell (LLC) number and to evaluate the expression of steroidogenic enzymes (HSD3B1, STAR, CYP11A1). Only hCG and GnRH treated ewes generated acc-CL. The LLC in both po- and acc-CL were significantly greater in the hCG group compared to GnRH and Control groups (P<0.05). Overall, hCG group showed the greatest immunodetection of HSD3B1and STAR in both po- and acc-CL (P<0.05). rnRNA expression of HSD3B1, STAR and CYP11A1 in the acc-CL tended to be greater in hCG group than in GnRH group (P<0.1). The LH concentration was increased in GnRH group (P<0.05) and P4 concentration was greater in hCG group compared to the other groups (P<0.05). In conclusion, administration of hCG has a notably impact on acc-CL development and the expression of steroidogenic enzymes compared to GnRH treatment in ewes. This leads to elevated P4 concentration and improved luteal function.

Monitoring of Body Condition in Dairy Cows to Assess Disease Risk at the Individual and Herd Level.

A retrospective longitudinal study assessing the explanatory and predictive capacity of body condition score (BCS) in dairy cows on disease risk at the individual and herd level was carried out. Data from two commercial grazing herds from the Argentinean Pampa were gathered (Herd A = 2100 and herd B = 2600 milking cows per year) for 4 years. Logistic models were used to assess the association of BCS indicators with the odds for anestrus at the cow and herd level. Population attributable fraction (AFP) was estimated to assess the anestrus rate due to BCS indicators. We found that anestrus risk decreased in cows calving with BCS ≥ 3 and losing ≤ 0.5 (OR: 0.07-0.41), and that anestrus rate decreased in cohorts with a high frequency of cows with proper BCS (OR: 0.22-0.45). Despite aggregated data having a good explanatory power, their predictive capacity for anestrus rate at the herd level is poor (AUC: 0.574-0.679). The AFP varied along the study in both herds and tended to decrease every time the anestrous rate peaked. We conclude that threshold-based models with BCS indicators as predictors are useful to understand disease risk (e.g., anestrus), but conversely, they are useless to predict such multicausal disease events at the herd level.

Neuroendocrine control of brown adipocyte function by prolactin and growth hormone.

Growth hormone (GH) is fundamental for growth and glucose homeostasis, and prolactin for optimal pregnancy and lactation outcome, but additionally, both hormones have multiple functions that include a strong impact on energetic metabolism. In this respect, prolactin and GH receptors have been found in brown, and white adipocytes, as well as in hypothalamic centers regulating thermogenesis. This review describes the neuroendocrine control of the function and plasticity of brown and beige adipocytes, with a special focus on prolactin and GH actions. Most evidence points to a negative association between high prolactin levels and the thermogenic capacity of BAT, except in early development. During lactation and pregnancy, prolactin may be a contributing factor that limits unneeded thermogenesis, downregulating BAT UCP1. Furthermore, animal models of high serum prolactin have low BAT UCP1 levels and whitening of the tissue, while lack of Prlr induces beiging in WAT depots. These actions may involve hypothalamic nuclei, particularly the DMN, POA and ARN, brain centers that participate in thermogenesis. Studies on GH regulation of BAT function present some controversies. Most mouse models with GH excess or deficiency point to an inhibitory role of GH on BAT function. Even so, a stimulatory role of GH on WAT beiging has also been described, in accordance with whole-genome microarrays that demonstrate divergent response signatures of BAT and WAT genes to the loss of GH signaling. Understanding the physiology of BAT and WAT beiging may contribute to the ongoing efforts to curtail obesity.

A simple method to select high superovulatory responder goats.

In most female mammals, a common drawback to multiple ovulation embryo transfer programs is the variability in the superovulatory response to the multidose pFSH treatment. The aim of the present study was to identify embryo donor goats based on their response to superovulation before the performance of a high-cost hormonal treatment, as we have previously done in sheep. To this end, we evaluated the number of ovulations obtained in response to the administration of a one-shot eCG treatment and related it with the subsequent ovarian response to a multiple-dose pFSH treatment in 33 goats of the Criolla-Neuquina breed. Goats received a one-shot eCG treatment of 800 IU at the end of a 17-day progestational treatment; 9 days later, started a second 17-day progestational treatment and then received a multiple-dose pFSH treatment on days 15-17 (116 mg pFSH, in six decreasing doses). The number of corpora lutea (CL) per goat was recorded laparoscopically after both hormonal treatments. On day 8 after the second pessary removal, embryos were surgically recovered and classified by quality. Results showed a significant positive correlation between the number of CL obtained in response to the eCG and pFSH treatments (r = 0.41; y = 0.8352x + 6.9906; P < 0.05), although of limited value to select high ovulatory responding goats, due to its low correlation value. Then, goats were grouped into high and low ovulatory responders to the eCG (High ≥9; Low <9 CL) and pFSH treatments (High ≥13; Low <13 CL). After the eCG and pFSH treatments, 60% of the goats maintained their classification as high or low superovulatory responders (expressed as recurrence rate). Significant differences were found in the number of CL (18.2 ± 1.3 vs 9.9 ± 1.3), number of embryos + oocytes (13.5 ± 1.7 vs 7.6 ± 1.7), number of embryos (10.8 ± 1.4 vs 5.1 ± 1.4) and number of Grade 1 and Grade 2 embryos (8.8 ± 1.4 vs 4.3 ± 1.4) between high and low superovulatory responder goats (P < 0.05), while no differences were observed in the number of oocytes and in the recovery of embryos + oocytes, embryos, Grade 1 and Grade 2 embryos and fertilization rates (P > 0.05). In conclusion, the recurrence rate in ovarian response between the one-shot eCG treatment and the multiple-dose pFSH treatment would confirm the existence of an "individual or intrinsic factor" of the donor goat that would respond as a high or low ovulatory responder to superovulatory treatments.

A successful vitrification technique for goat morulae conservation.

The aim of this study was to evaluate the effect of different vitrification and warming processes on the in vitro embryo survival of caprine morulae, considering the day of recovery. A total of 136 morulae of Criolla-Neuquina goats recovered on Days 7 or 8 after sponge removal, were exposed to three different vitrification processes; V1 (n = 48): glycerol (G) + ethylene glycol (EG); V2 (n = 44): EG + 0.5 M sucrose and V3 (n = 44): G + EG + 0.5 M sucrose. The morulae of each vitrification process were randomly assigned to three warming processes; W1 (n = 45): 0.5 M sucrose at 25 °C; W2 (n = 44): 0.5 M sucrose at 39 °C; and W3 (n = 47): solution containing half the concentration of the cryoprotectants + 0.5 M sucrose at 25 °C. After, embryos were cultured in 100 µL TCM 199 drops under mineral oil, at 39 °C and a 6.5% CO2 atmosphere for 72 h according to the different treatments. There were no viable embryos in V1 and V2 in none of their three respective warmings. Only V3 showed an embryo survival rate to hatched blastocyst stage of 59.1%. When considering embryo survival according to the warming processes, the survival rate was higher in V3W2 (76.9%) and V3W3 (66.7%) groups compared to the V3W1 group (37.5%; P < 0.05). The embryo survival of V3 for Day 8 after sponge removal (81.3%) was higher compared to Day 7 (46.4%; P < 0.05). In conclusion, a successful embryo survival is obtained by using a combination of cryoprotectants (G + EG) with addition of sucrose in the vitrification process for conservation of caprine morulae in embryo transfer programs. The survival rates in vitro of vitrified-warmed morulae in goats were influenced by their recovery day. Further studies should be conducted to determine if these results are reproducible in vivo embryo transfer on field situations.

Endometritis treatment with a PGF2alpha analog does not improve reproductive performance in a large dairy herd in Argentina.

In Argentina, most dairy cows with endometritis are treated with prostaglandin (PGF(2alpha) or its analogs) and insemination is withheld until there are no signs of endometritis. The objective of the present study was to evaluate if this method of managing endometritis enhances reproductive performance. Three experiments were conducted over 4 years in a large farm in the west of Buenos Aires province. In Experiment 1, half of the cows diagnosed with endometritis (>1.5-fold difference in diameter of uterine horns, as determined by rectal palpation) received standard endometritis management (treatment with tiaprost, a PGF(2alpha) analog, rectal palpation every 20 days, and withholding of AI until endometritis apparently resolved) and the other half was untreated, with AI at the first estrus after the voluntary waiting period. Untreated cows were inseminated and conceived 20 days earlier than treated cows, and the pregnancy rate by Day 90 postpartum was higher in the untreated group. In Experiment 2, cows with endometritis were divided into four groups according to the severity of symptoms; within each group, cows were allocated to treatment or control, as in Experiment 1. Although first service conception rate decreased as endometritis severity increased, reproductive performance in treated versus control cows was similar to that of Experiment 1 (with no interaction due to degree of endometritis). Re-evaluation of the treated cow (to confirm uterine "normality") may have been responsible for the delay in conception in both experiments. The objective of Experiment 3 was to determine the effects of tiaprost treatment on clinically normal postpartum cows (no evidence of endometritis). Tiaprost treatment reduced the interval from calving to conception in multiparous cows, but it delayed conception and reduced the conception rate in primiparous cows. In conclusion, treatment with tiaprost impaired reproductive performance in primiparous cows (in the absence of endometritis). Furthermore, the standard treatment for endometritis (treatment with a prostaglandin analog and withholding insemination until clinical signs abated) impaired reproductive performance and increased costs.